2022 -2024 Senior Vice President, Corporate Development (Eidos Therapeutics and Calcilytix Therapeutics) @
2020 -2022 Vice President, Corporate Development (Eidos Therapeutics and Calcilytix Therapeutics) @
2018 -2020 Senior Director, Corporate Development (Eidos Therapeutics and Calcilytix Therapeutics) @
2018 -2020 Advisor @
2014 -2018 New Products Planning @
2013 -2013 Business Development and Strategic Intelligence @
2013 -2020 Advisor @
2010 -2012 Analyst @
2009 -2009 Process Research and Development Engineer @
2007 -2010 Research Assistant @
2007 -2007 Researcher Assistant @
Ananth Sridhar Education
Harvard Business School
Master of Business Administration (MBA)
Stanford University
B.S. with Honors (Chemical Engineering)
Ananth Sridhar Skills
Data Analysis
Matlab
Biotechnology
Life Sciences
Molecular Biology
Leadership
Pharmaceutical Industry
Strategic Planning
Strategy
Microsoft Office
Ananth Sridhar Summary
Ananth Sridhar, based in United States, is currently a Chief Executive Officer, BridgeBio Endocrinology (Calcilytix Therapeutics) at BridgeBio. Ananth Sridhar brings experience from previous roles at BridgeBio. Ananth Sridhar holds a Master of Business Administration (MBA) @ Harvard Business School. With a robust skill set that includes Data Analysis, Matlab, Biotechnology, Life Sciences, Molecular Biology and more. Ananth Sridhar has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Ananth Sridhar?
Find contact details for 700 million professionals.